1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Gene Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2030
1.2.2 Oncolytic Virotherapy
1.2.3 Gene Transfer
1.2.4 Gene-Induced Immunotherapy
1.3 Market by Application
1.3.1 Global Cancer Gene Therapy Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostics Centers
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Gene Therapy Market Perspective (2018-2030)
2.2 Cancer Gene Therapy Growth Trends by Region
2.2.1 Cancer Gene Therapy Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 Cancer Gene Therapy Historic Market Size by Region (2018-2023)
2.2.3 Cancer Gene Therapy Forecasted Market Size by Region (2023-2030)
2.3 Cancer Gene Therapy Market Dynamics
2.3.1 Cancer Gene Therapy Industry Trends
2.3.2 Cancer Gene Therapy Market Drivers
2.3.3 Cancer Gene Therapy Market Challenges
2.3.4 Cancer Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Gene Therapy Players by Revenue
3.1.1 Global Top Cancer Gene Therapy Players by Revenue (2018-2023)
3.1.2 Global Cancer Gene Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Cancer Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Gene Therapy Revenue
3.4 Global Cancer Gene Therapy Market Concentration Ratio
3.4.1 Global Cancer Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Gene Therapy Revenue in 2022
3.5 Cancer Gene Therapy Key Players Head office and Area Served
3.6 Key Players Cancer Gene Therapy Product Solution and Service
3.7 Date of Enter into Cancer Gene Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Gene Therapy Breakdown Data by Type
4.1 Global Cancer Gene Therapy Historic Market Size by Type (2018-2023)
4.2 Global Cancer Gene Therapy Forecasted Market Size by Type (2023-2030)
5 Cancer Gene Therapy Breakdown Data by Application
5.1 Global Cancer Gene Therapy Historic Market Size by Application (2018-2023)
5.2 Global Cancer Gene Therapy Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Cancer Gene Therapy Market Size (2018-2030)
6.2 North America Cancer Gene Therapy Market Size by Country (2018-2023)
6.3 North America Cancer Gene Therapy Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cancer Gene Therapy Market Size (2018-2030)
7.2 Europe Cancer Gene Therapy Market Size by Country (2018-2023)
7.3 Europe Cancer Gene Therapy Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Gene Therapy Market Size (2018-2030)
8.2 Asia-Pacific Cancer Gene Therapy Market Size by Country (2018-2023)
8.3 Asia-Pacific Cancer Gene Therapy Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cancer Gene Therapy Market Size (2018-2030)
9.2 Latin America Cancer Gene Therapy Market Size by Country (2018-2023)
9.3 Latin America Cancer Gene Therapy Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Gene Therapy Market Size (2018-2030)
10.2 Middle East & Africa Cancer Gene Therapy Market Size by Country (2018-2023)
10.3 Middle East & Africa Cancer Gene Therapy Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Adaptimmune
11.1.1 Adaptimmune Company Detail
11.1.2 Adaptimmune Business Overview
11.1.3 Adaptimmune Cancer Gene Therapy Introduction
11.1.4 Adaptimmune Revenue in Cancer Gene Therapy Business (2018-2023)
11.1.5 Adaptimmune Recent Development
11.2 Bluebird bio
11.2.1 Bluebird bio Company Detail
11.2.2 Bluebird bio Business Overview
11.2.3 Bluebird bio Cancer Gene Therapy Introduction
11.2.4 Bluebird bio Revenue in Cancer Gene Therapy Business (2018-2023)
11.2.5 Bluebird bio Recent Development
11.3 Celgene
11.3.1 Celgene Company Detail
11.3.2 Celgene Business Overview
11.3.3 Celgene Cancer Gene Therapy Introduction
11.3.4 Celgene Revenue in Cancer Gene Therapy Business (2018-2023)
11.3.5 Celgene Recent Development
11.4 Shanghai Sunway Biotech
11.4.1 Shanghai Sunway Biotech Company Detail
11.4.2 Shanghai Sunway Biotech Business Overview
11.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Introduction
11.4.4 Shanghai Sunway Biotech Revenue in Cancer Gene Therapy Business (2018-2023)
11.4.5 Shanghai Sunway Biotech Recent Development
11.5 Shenzhen SiBiono GeneTech
11.5.1 Shenzhen SiBiono GeneTech Company Detail
11.5.2 Shenzhen SiBiono GeneTech Business Overview
11.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Introduction
11.5.4 Shenzhen SiBiono GeneTech Revenue in Cancer Gene Therapy Business (2018-2023)
11.5.5 Shenzhen SiBiono GeneTech Recent Development
11.6 SynerGene Therapeutics
11.6.1 SynerGene Therapeutics Company Detail
11.6.2 SynerGene Therapeutics Business Overview
11.6.3 SynerGene Therapeutics Cancer Gene Therapy Introduction
11.6.4 SynerGene Therapeutics Revenue in Cancer Gene Therapy Business (2018-2023)
11.6.5 SynerGene Therapeutics Recent Development
11.7 Altor BioScience
11.7.1 Altor BioScience Company Detail
11.7.2 Altor BioScience Business Overview
11.7.3 Altor BioScience Cancer Gene Therapy Introduction
11.7.4 Altor BioScience Revenue in Cancer Gene Therapy Business (2018-2023)
11.7.5 Altor BioScience Recent Development
11.8 Amgen
11.8.1 Amgen Company Detail
11.8.2 Amgen Business Overview
11.8.3 Amgen Cancer Gene Therapy Introduction
11.8.4 Amgen Revenue in Cancer Gene Therapy Business (2018-2023)
11.8.5 Amgen Recent Development
11.9 Argenx
11.9.1 Argenx Company Detail
11.9.2 Argenx Business Overview
11.9.3 Argenx Cancer Gene Therapy Introduction
11.9.4 Argenx Revenue in Cancer Gene Therapy Business (2018-2023)
11.9.5 Argenx Recent Development
11.10 BioCancell
11.10.1 BioCancell Company Detail
11.10.2 BioCancell Business Overview
11.10.3 BioCancell Cancer Gene Therapy Introduction
11.10.4 BioCancell Revenue in Cancer Gene Therapy Business (2018-2023)
11.10.5 BioCancell Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Detail
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline Cancer Gene Therapy Introduction
11.11.4 GlaxoSmithKline Revenue in Cancer Gene Therapy Business (2018-2023)
11.11.5 GlaxoSmithKline Recent Development
11.12 Merck
11.12.1 Merck Company Detail
11.12.2 Merck Business Overview
11.12.3 Merck Cancer Gene Therapy Introduction
11.12.4 Merck Revenue in Cancer Gene Therapy Business (2018-2023)
11.12.5 Merck Recent Development
11.13 OncoGenex Pharmaceuticals
11.13.1 OncoGenex Pharmaceuticals Company Detail
11.13.2 OncoGenex Pharmaceuticals Business Overview
11.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Introduction
11.13.4 OncoGenex Pharmaceuticals Revenue in Cancer Gene Therapy Business (2018-2023)
11.13.5 OncoGenex Pharmaceuticals Recent Development
11.14 Transgene
11.14.1 Transgene Company Detail
11.14.2 Transgene Business Overview
11.14.3 Transgene Cancer Gene Therapy Introduction
11.14.4 Transgene Revenue in Cancer Gene Therapy Business (2018-2023)
11.14.5 Transgene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
